"CD56 Antigen" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The 140 kDa isoform of NCAM (neural cell adhesion molecule) containing a transmembrane domain and short cytoplasmic tail. It is expressed by all lymphocytes mediating non-MHC restricted cytotoxicity and is present on some neural tissues and tumors.
| Descriptor ID |
D019002
|
| MeSH Number(s) |
D12.776.395.550.200.250.520.156 D12.776.543.550.200.250.520.156 D23.050.301.264.894.156 D23.050.301.350.250.520.156 D23.101.100.894.156
|
| Concept/Terms |
CD56 Antigen- CD56 Antigen
- Antigen, CD56
- Leu-19 Antigen
- Antigen, Leu-19
- Leu 19 Antigen
- Antigens, CD56
- NKH-1 Antigen
- Antigen, NKH-1
- NKH 1 Antigen
- CD56 Antigens
|
Below are MeSH descriptors whose meaning is more general than "CD56 Antigen".
- Chemicals and Drugs [D]
- Amino Acids, Peptides, and Proteins [D12]
- Proteins [D12.776]
- Glycoproteins [D12.776.395]
- Membrane Glycoproteins [D12.776.395.550]
- Cell Adhesion Molecules [D12.776.395.550.200]
- Cell Adhesion Molecules, Neuronal [D12.776.395.550.200.250]
- Neural Cell Adhesion Molecules [D12.776.395.550.200.250.520]
- CD56 Antigen [D12.776.395.550.200.250.520.156]
- Membrane Proteins [D12.776.543]
- Membrane Glycoproteins [D12.776.543.550]
- Cell Adhesion Molecules [D12.776.543.550.200]
- Cell Adhesion Molecules, Neuronal [D12.776.543.550.200.250]
- Neural Cell Adhesion Molecules [D12.776.543.550.200.250.520]
- CD56 Antigen [D12.776.543.550.200.250.520.156]
- Biological Factors [D23]
- Antigens [D23.050]
- Antigens, Surface [D23.050.301]
- Antigens, Differentiation [D23.050.301.264]
- Antigens, Differentiation, T-Lymphocyte [D23.050.301.264.894]
- CD56 Antigen [D23.050.301.264.894.156]
- Cell Adhesion Molecules [D23.050.301.350]
- Cell Adhesion Molecules, Neuronal [D23.050.301.350.250]
- Neural Cell Adhesion Molecules [D23.050.301.350.250.520]
- CD56 Antigen [D23.050.301.350.250.520.156]
- Biomarkers [D23.101]
- Antigens, Differentiation [D23.101.100]
- Antigens, Differentiation, T-Lymphocyte [D23.101.100.894]
- CD56 Antigen [D23.101.100.894.156]
Below are MeSH descriptors whose meaning is more specific than "CD56 Antigen".
This graph shows the total number of publications written about "CD56 Antigen" by people in this website by year, and whether "CD56 Antigen" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 1 | 1 | 2 |
| 2009 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2014 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "CD56 Antigen" by people in Profiles.
-
Hughes T, Briercheck EL, Freud AG, Trotta R, McClory S, Scoville SD, Keller K, Deng Y, Cole J, Harrison N, Mao C, Zhang J, Benson DM, Yu J, Caligiuri MA. The transcription Factor AHR prevents the differentiation of a stage 3 innate lymphoid cell subset to natural killer cells. Cell Rep. 2014 Jul 10; 8(1):150-62.
-
Magro CM, Porcu P, Schaefer J, Erter JW, Furman RR, Shitabata PK, Crowson AN. Cutaneous CD4+ CD56+ hematologic malignancies. J Am Acad Dermatol. 2010 Aug; 63(2):292-308.
-
Yu J, Mao HC, Wei M, Hughes T, Zhang J, Park IK, Liu S, McClory S, Marcucci G, Trotta R, Caligiuri MA. CD94 surface density identifies a functional intermediary between the CD56bright and CD56dim human NK-cell subsets. Blood. 2010 Jan 14; 115(2):274-81.
-
Trotta R, Parihar R, Yu J, Becknell B, Allard J, Wen J, Ding W, Mao H, Tridandapani S, Carson WE, Caligiuri MA. Differential expression of SHIP1 in CD56bright and CD56dim NK cells provides a molecular basis for distinct functional responses to monokine costimulation. Blood. 2005 Apr 15; 105(8):3011-8.
-
Becknell B, Trotta R, Yu J, Ding W, Mao HC, Hughes T, Marburger T, Caligiuri MA. Efficient infection of human natural killer cells with an EBV/retroviral hybrid vector. J Immunol Methods. 2005 Jan; 296(1-2):115-23.